key: cord-1029245-y4zwaowh
authors: Pablos-Méndez, Ariel; Villa, Simone; Monti, Maria Cristina; Raviglione, Mario Carlo; Tabish, Hilary Brown; Evans, Timothy Grant; Cash, Richard Alan
title: Global ecological analysis of COVID-19 mortality and comparison between “the East” and “the West”
date: 2022-03-28
journal: Sci Rep
DOI: 10.1038/s41598-022-09286-7
sha: a4f1feb2998b0f91a65b3d9b43715d45dc8a0896
doc_id: 1029245
cord_uid: y4zwaowh

Although SARS-CoV-2 was first reported in China and neighbouring countries, the pandemic quickly spread around the globe. This paper explores national drivers of the pandemic and the radically different epidemiology and response in the West and in the East. We studied coronavirus disease (COVID-19) mortality until 31st December 2020, using an ecological study design, considering baseline characteristics and responses that might account for the uneven impact of the pandemic. A multivariable regression model was developed to explore key determinants. Key variables in the West were contrasted with those in the East, and speed of response was examined. Worldwide, 2.24 million COVID-19 deaths were documented in 2020. Western countries reported a median mortality 114 times that of the East (684 vs. 6.0 per million). Significant correlates of mortality in countries with at least 1 million population were median age, obesity prevalence, and democracy index; political stability and experience of SARS in 2002–2003 were protective; health system variables and income inequality were not associated. Outputs of the model were consistent when adjusted for stringency index, timeliness of stay-at-home requirements, and geographical autocorrelation. The West experiences a much higher COVID-19 mortality than the East. Despite structural advantages in the West, delays in national responses early on resulted in a loss of control over the spread of SARS-CoV-2. Although the early success of the East was sustained in the second half of 2020, the region remains extremely vulnerable to COVID-19 until enough people are immunized.

Although the COVID-19 pandemic originated in China and quickly spread throughout Asia, it has had a far greater impact in the western world 1 . Within a few months of the outbreak, the epicentre of the pandemic shifted from Asia to Europe and then to the Americas. In addition to the grim impact on both physical and mental health in Europe and the Americas, lockdowns in the West caused wide-spread economic damage, the impact of which is likely to persist for years 2, 3 .

During 2020 the COVID-19 mortality rates reported for North America and Europe were 114 times higher than in Western Pacific and South East Asian countries. 11 The success of the East suggests the catastrophe of what ensued in the West could have been avoided. The ability of the East to prevent and manage SARS-CoV-2 transmission begs the question of how this was possible when advanced economies in the West, with established democracies and well-equipped health infrastructure, failed to contain the exponential growth. This paper explores several potential answers to these questions by reporting on an ecological analysis that compares COVID-19 mortality with baseline country characteristics and national interventions and by focusing on the differences between the East and the West.

We conducted an ecological analysis to describe and investigate the uneven impact of the COVID-19 pandemic in countries with at least 1 million population. Statistical plan. Quantitative variables were reported as median and range. COVID-19 deaths per million were logarithmically transformed to normalize the distribution of data. Likewise, gross domestic product (GDP) per capita, population size, and number of air travel passengers were non-normally distributed and consequently logarithmically transformed. All continuous exploratory variables were standardized before their inclusion in the ordinary least squares (OLS) regression models.

The association of the log of COVID-19 deaths per million with likely explanatory variables was further investigated using the Minimum Covariance Determinant (MCD) estimator and regression models with robust standard errors. For multiple OLS regressions, three exploratory sub-models were developed and tested based on specific domains described above. Statistically significant covariates, selected using a stepwise backward selection process, were merged in a unified final exploratory model. The inclusion of interaction terms in the regression models were considered, testing for non-additive effects of different combinations of predictor variables on the dependent variable. Issues of heterogeneity of variance, intragroup correlation and sensitivity to outliers were considered. A model-based clustering and classification estimation was used for corroborating the arbitrary West and East grouping. Additional information is available in the supplementary materials.

Statistical analysis was performed using STATA version 16.1 (StataCorp, College Station, Texas, USA) or R version 4.0.3 was used for the cluster analysis using the package mclust 4 .

Demographics and health risk factors. As displayed in Table 1 , the global median GDP per capita was 5,152 (range, 369 to 80,504) US dollars in 2019, the estimated proportion of the population aged 65 or older was 6.7% (range, 1.3-28.4%) in 2020, and the median prevalence of obesity was 20.2% (range, 2.1 to 37.9%).

There was a positive and strong association between the log of GDP per capita and the log of COVID-19 mortality (MCD = 0.808, b = 0.512, p < 0.001). Likewise, age was associated with increased mortality both as median age (MCD = 0.803, b = 0.509, p < 0.001) and as proportion of population 65 + years of age (MCD = 0.744, b = 0.480, p < 0.001). While a higher proportion of the population living in urban settings was positively associated to COVID-19 mortality (MCD = 0.621, b = 0.484, p < 0.001), living in crowded households had an inverse association (MCD = -0.660, b = −0.491, p < 0.001).

Several health risks beyond age have been associated with poor COVID-19 outcomes. Prevalence of obesity, in particular, had a strong positive association with COVID-19 mortality (MCD = 0.674, b = 0.591, p < 0.001) followed by while the prevalence of raised blood pressure had a strong negative association with COVID-19 mortality (MCD = −0.486, b = −0.267, p < 0.001).

Health system preparedness and response indicators. Several preparedness indicators were significantly associated with COVID-19 mortality (Table 2 ). In particular, the service coverage index of universal health coverage (UHC) was positively associated with COVID-19 mortality (MCD = 0.718, b = 0.537, p = 0.002), as was the density of medical doctors (MCD = 0.584, b = 0.493, p < 0.001). Notably, scores used specifically to evaluate countries' preparedness, like the average score from the country self-reporting preparedness within the www.nature.com/scientificreports/ Exploratory multivariable models. We developed three domain-specific OLS regression sub-models (Table S4 ). Only five variables were found to be associated with COVID-19 mortality in the final multivariate model (Table S5 and Fig. 1 ) and the significance of the outputs remained unchanged once adjusted for response measures (Table S6 ). The final adjusted OLS model, further refined by removing outliers as described in the supplementary results and in Figure S6 , is reported in www.nature.com/scientificreports/ p < 0.001) emerged as protective factors against COVID-19 mortality. The significance of the model was further tested for the geographical autocorrelation with only previous SARS cases losing its significance (Fig. 1) . Figure 2 displays the trends of COVID-19 mortality in the two regions throughout the 2020. The West had a median GDP per capita 8-times higher than the East, and their populations were older (median age 43.2 vs. 31.4 years, respectively)( Table 3) . Western countries were more urbanized, while the East had a higher proportion of households with 4 or more members (median 58.6 vs. 22.2%). The prevalence of obesity was much higher in the West (median 23.1%) than in the East (6.2%), and only slightly more so for smoking.

The West had significantly better indicators of pandemic preparedness (ie, IHR and GHS indices), health system performance (ie, density of medical doctors, hospital beds), and health spending. Two thirds of the countries in the East experienced SARS in 2002-2003 compared to 37% in the West. Western countries had better indicators of governance, literacy and income inequality, and were more likely to enjoy political stability free of violence compared to the East. Lastly, of the countries included in this analysis more countries in the East were islands than in the West (33.3% vs. 7.4%).

When analysing how the subset of countries clustered based on the Table 2 features, we corroborated the empirical East-West classification. However, countries of the Eastern Europe were observed to form a distinct cluster compared to countries of the Western Europe and North America. (details and plots in the supplementary results). Fig. 2 , the cumulative mortality from COVID-19 in the West skyrocketed nearly 8000-fold from March 1st to May 31st, but only 4.5 times in the East; from May 31st to December 31 st the relative increases were 2.9 and 6.0, respectively.

The East and the West had a similar stringency index for their response to COVID-19, but the West was delayed and more reactive and it failed to halt an early and catastrophic exponential rise in cases and deaths ( Table 4 ). The effective reproduction rate for COVID-19 was higher in the first quarter of 2020, and more so in the West vs. the East; the opposite was true for the stringency of the response. The positive rate of tests performed was much higher in the West.

In the East internet users increased searches for masks at the end of January, while the West such web-searches were delayed until March-April (Fig. 3) . The temporal delay persists after adjusting for the date of each country's first confirmed case.

In 2020, there were 2.24 million confirmed COVID-19 deaths reported worldwide and this figure is estimated to surpass 10 million in reality 5 . Significant elements positively associated with increased COVID-19 mortality were median age, obesity prevalence, and EIU democracy index; political stability and previous SARS cases were associated with lower mortality. Despite having robust economies and health systems, Western countries experienced a COVID-19 mortality 114-times higher than countries in the East. Aging 5 and obesity 6 , well established Disappointingly, the GHS index, the average score of IHR self-assessment, UHC, and the density of both hospital beds and medical doctors did not seem to protect against COVID-19 mortality. Structural factors played a less significant role at the global level, including the Gini coefficient which has been established as important at the subnational level 7 . The index used to measure political stability was associated with lower COVID-19 mortality, while, the EIU democracy index was associated with worse COVID-19 mortality; this suggests that 

Avg www.nature.com/scientificreports/ authoritarian regimes with command-and-control leadership and more pliable societies may have been more effective in containing the epidemic 8 . Delays in responding to the pandemic may have played a large role in the health and social crisis. The reproduction number of COVID-19 was much higher in the West in the first quarter of 2020 and cumulative mortality skyrocketed nearly 8,000-fold from March 1 st to May 31 st , but rose less than tenfold in the East and from May 31 st to December 31 st . During the first quarter of 2020, Asian countries tested 2.7 times more patients per reported COVID-19 case than in Western countries 9 . Testing is paramount not only for surveillance but for early contact-tracing and prompt isolation 10 -time-honoured public health measures that South Korea and other neighbouring countries implemented early and with rigor. Similarly, the use of face masks was more prevalent in Asia 11 and interest in them surged several weeks before they did in the West. In addition to masks becoming politicized in the West 12 , their slow uptake in this region may have been due to the WHO's slow recognition of the effectiveness of masks and therefore lack of leadership in this area 13 .

Interestingly, countries that reported local SARS outbreaks in 2002-2003 had a lower COVID-19 mortality in 2020. While the viruses causing SARS and COVID-19 are closely related, protective cross-immunity in 2020 is improbable because of the very limited number of SARS cases and relatively short duration of neutralizing antibodies 14 . More plausible, the "social memory" derived from experiencing a highly lethal outbreak and associated economic shock, especially in Asia, may have contributed to a faster and consistent response at individual and community levels. Conversely the West, with more robust economies and stronger health systems, may have been overconfident causing delays in response and losing control of the epidemic early on which ultimately required more drastic countermeasures 15 . The costs of lock-downs will persist over several years and will impact both the political economy as well as the physical and mental health of the population.

In the summer of 2020, there was concern that the lack of population-level immunity and exhaustion with strict behavioural measures would lead to a spike of COVID-19 deaths in the East by the end of the year like the one experienced by the West in the spring. Instead, the West missed a second chance at controlling the pandemic 16 and experienced an even greater wave (in absolute numbers) by the end of 2020. This included Sweden, whose more liberal (and sustainable) policies permitted the un-interrupted transmission of the virus among young and healthy people 17 . A sustained response to COVID-19 was clearly more important than slowly growing levels of natural immunity 18 .

With much lower levels of natural immunity in 2021 19 , Asian populations remain very vulnerable to COVID-19 as documented by the rapidly increasing burden in some countries in the first half of 2021. This is a clear signal that these countries should not lower their guard until enough people are vaccinated, starting with the elderly, health care workers and other vulnerable populations. The wave of cases in India in early 2021 is a case in point, as is the recent increase in mortality rates in Taiwan, Japan and Thailand. 11 The prognosis in Africa, also reporting low COVID-19 mortality in 2020, is less clear given its younger population 20 . www.nature.com/scientificreports/ This study has some limitations as data from different sources of data are far from perfect nor complete and do not disaggregate by key elements such as age or socioeconomic status. Further, numerous COVID-19 cases, as well as deaths, likely went undetected or unreported which may have been more prevalent in the East. 20 Noteworthy, different types of definitions were used by countries to define a COVID-19 death, either using the current WHO definition (i.e., clinical diagnosis-based for confirmed and probable cases) 21 or a test-based diagnosis 22 . To attenuate this challenge our analysis focused on mortality rather than incidence. We did not analyze the importance of culture, climate change or biological indicators (genetics, mutations), although we note that in the United States persons of Asian descent had the same COVID-19 mortality as non-Hispanic Whites 23 . Several paradoxical findings in univariate analyses, like higher mortality in countries with better health preparedness indicators, may have been confounded by higher case detection or, more likely, by delays activating their public health capability before contagion spun out of control. Furthermore, as described with the availability and reliability of data on COVID-19 epidemiology, other predictors used in the models might be affected by the same under-estimation (e.g. obesity prevalence and median age). These, however, are estimated from international organizations, while COVID-19 cases and deaths are those directly reported by countries and not based on estimates accounting for under-reporting.

The East was successful in stopping the exponential first phase of COVID-19 in 2020, while the West has suffered mortality rates 114 times higher. Older age and obesity emerged as significant ecological risk factors for COVID-19 and might have contributed to the vast differences between these two regions. Rapid response from governments, including early lock-downs in China, higher testing coverage per case in South Korea, and early mask wearing in most of Asia may have contributed to the East's ability to contain the epidemic. Similarly, countries that experienced SARS in 2002-2003 had lower deaths from COVID-19 in 2020 24 . Whereas delays in response and ineffective leadership and communication hindered western countries' ability to control the virus, despite their stronger economies and more robust health systems 25,26 , While the early success of the East was sustained throughout 2020, low natural immunity in the region requires continued public health vigilance until threshold levels of vaccination-acquired immunity are reached or the virus otherwise disappears from the face of the Earth. Weekly trend in online searches of "face masks" in Google, expressed in RSV (%), in the West (in red) and in the East (in purple). As extensively explained in the supplementary materials, data from 1st December 2019 to 30th June 2020, accounting for 1-month period of baseline to account for possible confounding for some countries in the East with higher baseline values (ie, Japan and Viet Nam). Additional information on Google Trend RSV can be found in the supplementary methods.

Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: A modelling study

COVID-19 to plunge global economy into worst recession since World War II. The World Bank

Calling for benefit-risk evaluations of COVID-19 control measures

2016) mclust 5: Clustering, classification and density estimation using Gaussian finite mixture models

Severe Outcomes among patients with coronavirus disease 2019 (COVID-19) -United States

More severe obesity leads to more severe COVID-19 in study

Association between income inequality and countylevel COVID-19 cases and deaths in the US

The relationship between cultural tightness-looseness and COVID-19 cases and deaths: A global analysis

Our World in Data repository

COVID-19 Contact Tracing as an Enduringly Important Public Health Tool

COVID-19: Facemask use prevalence in international airports in Asia

Politicizing the mask: Political, economic and demographic factors affecting mask wearing behavior in the USA

Facial masking for Covid-19 -Potential for "Variolation" as We Await a Vaccine

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection

Association of mobile phone location data indications of travel and stay-at-home mandates with COVID-19 infection rates in the US

Change in reported adherence to nonpharmaceutical interventions during the COVID-19 pandemic

COVID-19 and the Swedish enigma

Association of SARS-CoV-2 seropositive antibody test with risk of future infection

SeroTracker: A global SARS-CoV-2 seroprevalence dashboard. The Lancet Infect

Seroprevalence surveys in sub-Saharan Africa: What do they tell us?

International Guidelines for Certification and Classification (Coding) of COVID-19 as Cause of Death

How Comparable is Covid-19 Mortality Across Countries?

COVID-19 Hospitalization and Death by Race/Ethnicity

Report of the independent panel for pandemic preparedness and response: Making COVID-19 the last pandemic

Revealed How Poorly the US Was Prepared for COVID-19-and Future Pandemics

Solidarity and universal preparedness for health after covid-19

/scientificreports/ Correspondence and requests for materials should be addressed to S.V. Reprints and permissions information is available at www.nature.com/reprints

We thank Dr. Lincoln Chen, former President of the China Medical Board (Boston, MA. USA), and Dr. Suwit Wibulproprasert, International Health Policy Partnership (Bangkok, Thailand) for their mentorship and support for this report.

The study was sponsored by the China Medical Board (CMB), an American Foundation in Boston, MA. USA. APM, SV, and HBT received funds from the CMB. There are no further competing financial/non-financial interests to disclose for MCM, MCR, TGE, and RAC.

The online version contains supplementary material available at https:// doi. org/ 10. 1038/ s41598-022-09286-7.Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.